Medline Inc.
MDLNNASDAQHealthcare● Active
$33.80
+$0.19(+0.57%)
Market Cap$28.6B
P/E Ratio—
52W High$50.876
52W Low$32.815
Medline Inc. (MDLN) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · MDLN · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 |
|---|---|---|---|---|
| Operating Activities | ||||
| Net Income | $1.16B | $1.20B | $0.23B | ($0.03B) |
| Depreciation & Amort. | $0.70B | $0.98B | $0.95B | $0.93B |
| Stock-Based Comp. | $0.00B | $0.00B | $0.00B | $0.00B |
| Change in Working Capital | $0.00B | ($0.68B) | $0.20B | ($0.92B) |
| Net Cash from Operations | $1.74B | $1.77B | $1.69B | $0.19B |
| Investing Activities | ||||
| Capital Expenditure | $0.00B | ($0.36B) | ($0.28B) | ($0.25B) |
| Purchases of Investments | $0.00B | $0.00B | ($0.02B) | $0.00B |
| Sales of Investments | $0.00B | $0.00B | $0.01B | $0.01B |
| Net Cash from Investing | ($0.47B) | ($1.49B) | ($0.31B) | ($0.26B) |
| Financing Activities | ||||
| Common Stock Repurchased | $0.00B | ($0.02B) | $0.00B | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | ($4.09B) | ($0.07B) | ($0.08B) | ($0.06B) |
| Net Cash from Financing | $0.40B | ($1.61B) | ($0.19B) | ($0.08B) |
| Free Cash Flow | ||||
| Free Cash Flow | $1.74B | $1.41B | $1.40B | ($0.07B) |
| FCF Margin %(computed) | 6.13% | 5.51% | 6.03% | -0.31% |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more Medline Inc. data
About Medline Inc. (MDLN) Cash Flow Statement
Medline Inc. generated operating cash flow of $1.74B and free cash flow of $1.74B for 2025 — a FCF margin of 6.13%. Capital expenditure was $0.00B.
Frequently asked questions
MDLN · 4 questionsMedline Inc. generated free cash flow of $1.74B for 2025, up 24.1% year-over-year.
MDLN free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10